Go

product on market Powder BPI Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The product contains carbohydrates and niacin, which support energy metabolism and cellular function. Evidence for these individual components is strong, though the proprietary GO Matrix limits the ability to assess specific dosage efficacy. Overall, the ingredient profile is supported by moderate to strong research for general energy support.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Go
Open Full PDF View on NIH DSLD →
Details

Label Data

5 Gram(s)
Serving Size
30
Servings
Other Combinations
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
6 {Calories}
Total Carbohydrates
1.5 Gram(s) (1% DV)
30 mg (150% DV)
2.1× RDA — within safe limits 196 studies (A:5, B:63)
GO(TM) MATRIX (Proprietary blend)
3635 mg

Other Ingredients

Maltodextrin Natural & Artificial flavors Silica Citric Acid Sucralose Acesulfame-K FD&C Red No. 40
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Important Note(s): Do not exceed one (1) serving (1 scoop) per training day. Avoid eating food or drinking a protein shake within an hour after consuming GO(TM). To avoid sleeplessness, do not take within four (4) hours of bedtime. Taking GO(TM) with food, or on a full stomach, may diminish its effects.

Suggested Use: Use on training days only. Take one (1) serving (1 scoop) approximately 15-30 minutes prior to training, blended into 6-8 ounces of cold water or beverage, or as suggested by a qualified healthcare practitioner.

Warnings & Precautions

Please read entire label before use.

Warnings: Not intended for use by persons under age 18.

Do not exceed recommended dose. Do not take for more than eight (8) consecutive weeks.

This product should not be taken by pregnant or lactating women. Get the consent of a licensed physician before using this product, especially if you are taking medication, have a medical condition, or thinking about becoming pregnant.

Too much caffeine may cause nervousness, irritability, sleeplessness, and occasionally rapid heartbeat. Discontinue use if you experience dizziness, severe headache, rapid heartbeat or shortness of breath.

Caffeine Warning: The recommended serving of this product contains approximately as much caffeine as three cups of coffee.

KEEP THIS PRODUCT AND ALL SUPPLEMENTS OUT OF THE REACH OF CHILDREN.

Do not consume caffeine, or combine with synephrine, including but not limited to coffee, tea, soda and other dietary supplements or medications containing phenylephrine or caffeine.

Additional Information

CarnoSyn(R) Carnosine Synthesizer

{Signature} Jay Cutler "THIS IS WHAT I TAKE" STACK

Many individuals notice the initial energy, mental focus, and volumizing effects within just 5-15 minutes of ingestion, with a progressive increase every few minutes thereafter. Others may begin to notice initial signs within 30-45 minutes of ingestion.

Rev. 01-001-TWT001 10/12

FREE INSIDE JAY'S T-SHIRT SHAKER CUP 4X MR. OLYMPIA POSTER

PRE-WORKOUT PERFORMANCE PRE-TRAINING POWDER

When combined with a proper exercise and nutrition regimen. Statements based on early-stage independent 3rd party in vivo and / or in vitro model scientific research data findings.

Jay Cutler 4X Mr. Olympia APPROVED 2006 / 2007 / 2009 / 2010

bpi EXT i

SUPPLEMENT WITH JAY'S STACK FOR A BETTER AND MORE DEFINING PHYSIQUE.

30 SERVINGS

Metadata

Product Details

UPC / SKU8 51780 00497 5
DSLD Entry Date2014-03-25
Product TypeOther Combinations
FormPowder
BrandBPI
DSLD ID31220
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.